JP2023510603A5 - - Google Patents

Info

Publication number
JP2023510603A5
JP2023510603A5 JP2022543410A JP2022543410A JP2023510603A5 JP 2023510603 A5 JP2023510603 A5 JP 2023510603A5 JP 2022543410 A JP2022543410 A JP 2022543410A JP 2022543410 A JP2022543410 A JP 2022543410A JP 2023510603 A5 JP2023510603 A5 JP 2023510603A5
Authority
JP
Japan
Prior art keywords
amyloid
chimeric receptor
domain
receptor according
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022543410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510603A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/013727 external-priority patent/WO2021146620A2/en
Publication of JP2023510603A publication Critical patent/JP2023510603A/ja
Publication of JP2023510603A5 publication Critical patent/JP2023510603A5/ja
Pending legal-status Critical Current

Links

JP2022543410A 2020-01-17 2021-01-15 アミロイド除去のためのキメラ抗原受容体 Pending JP2023510603A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062962763P 2020-01-17 2020-01-17
US62/962,763 2020-01-17
PCT/US2021/013727 WO2021146620A2 (en) 2020-01-17 2021-01-15 Chimeric antigen receptors for removal of amyloid

Publications (2)

Publication Number Publication Date
JP2023510603A JP2023510603A (ja) 2023-03-14
JP2023510603A5 true JP2023510603A5 (https=) 2024-01-23

Family

ID=76864318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022543410A Pending JP2023510603A (ja) 2020-01-17 2021-01-15 アミロイド除去のためのキメラ抗原受容体

Country Status (11)

Country Link
US (1) US20230068507A1 (https=)
EP (1) EP4090362A4 (https=)
JP (1) JP2023510603A (https=)
KR (1) KR20220129026A (https=)
CN (1) CN115175693A (https=)
AU (1) AU2021208630A1 (https=)
BR (1) BR112022013940A2 (https=)
CA (1) CA3164691A1 (https=)
IL (1) IL294740A (https=)
MX (1) MX2022008687A (https=)
WO (1) WO2021146620A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109553686A (zh) * 2017-09-26 2019-04-02 南京安吉生物科技有限公司 一种新型可调控的双嵌合抗原受体t细胞及其构建方法和应用
KR20230144525A (ko) * 2020-12-04 2023-10-16 유니버시티 오브 테네시 리서치 파운데이션 아밀로이드 질환을 진단하기 위한 방법
WO2024050478A1 (en) * 2022-09-02 2024-03-07 University Of Tennessee Research Foundation Chimeric antigen receptors for removal of amyloid
SE548109C2 (en) * 2023-03-28 2026-03-30 Cerimmune Therapeutics Ab Microglial endocytic receptors for use in the treatment of neurodegenerative disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526868A (ja) * 2007-05-14 2010-08-05 ノビミューン エスアー 改変されたエフェクター機能を有するFc受容体結合ポリペプチド
US10213506B2 (en) * 2014-08-26 2019-02-26 University Of Tennessee Research Foundation Targeting immunotherapy for amyloidosis
US20180186855A1 (en) * 2016-03-23 2018-07-05 Alector Llc Chimeric receptors and methods of use thereof
US11530257B2 (en) * 2017-06-29 2022-12-20 The Trustees Of Columbia University In The City Of New York Chimeric antibodies for treatment of amyloid deposition diseases
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
CN109837246A (zh) * 2017-11-25 2019-06-04 深圳宾德生物技术有限公司 一种敲除pd1的靶向ror1的嵌合抗原受体t细胞及其制备方法和应用
SG11202007171PA (en) * 2018-02-02 2020-08-28 Univ Pennsylvania Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregates
US11246513B2 (en) * 2018-02-08 2022-02-15 Senseonics, Incorporated Data management system communications with a display device in an analyte monitoring system

Similar Documents

Publication Publication Date Title
JP2023510603A5 (https=)
JP2019535268A5 (ja) アクチビンIIa型受容体変異体および同変異体を含む医薬組成物
JP2020519298A5 (https=)
JP2023518596A5 (https=)
JP2023504172A5 (https=)
JP2018171063A5 (https=)
JP2016533174A5 (https=)
JP2019514361A5 (https=)
JP2019521643A5 (https=)
JP2020517287A5 (https=)
JP2019531055A5 (https=)
JP2019501647A5 (https=)
JP2020506898A5 (https=)
JP2023528207A5 (https=)
JP2016528295A5 (https=)
JP2019519227A5 (https=)
JP2019514367A5 (https=)
JP2010254694A5 (https=)
JP2018510639A5 (https=)
JP2009201525A5 (https=)
JP2002500886A5 (https=)
Nilsson et al. Multiple affinity domains for the detection, purification and immobilization of recombinant proteins
JP2019530441A5 (https=)
JP2009529509A5 (https=)
JP2021518151A5 (https=)